United States : Regeneron's Bcmaxcd3 Bispecific Antibody (Regn5458) Shows Deep And Durable Responses In Patients With Heavily-pretreated Multiple Myeloma In Phase 1

  • Deepu Madduri

Press/Media

Period9 Dec 2020

Media coverage

1

Media coverage

  • TitleUnited States : Regeneron's Bcmaxcd3 Bispecific Antibody (Regn5458) Shows Deep And Durable Responses In Patients With Heavily-pretreated Multiple Myeloma In Phase 1
    Media name/outletTendersInfo – News
    Country/TerritoryIndia
    Date9/12/20
    PersonsDeepu Madduri
View all 1
View less